Computational, Experimental, and Clinical Evidence of a Specific but Peculiar Evolutionary Nature of (COVID-19) SARS-CoV-2

被引:6
作者
Goh, Gerard Kian-Meng [6 ]
Dunker, A. Keith [1 ]
Foster, James A. [2 ,3 ]
Uversky, Vladimir N. [4 ,5 ]
机构
[1] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA
[2] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA
[3] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83844 USA
[4] Univ S Florida, Morsani Coll Med, USF Hlth Byrd Alzheimers Res Inst, Dept Mol Med, Tampa, FL 33620 USA
[5] Russian Acad Sci, Fed Res Ctr, Inst Biol Instrumentat, Lab New Methods Biol,Pushchino Sci Ctr Biol Res, Pushchino 142290, Russia
[6] Gohs BioComp, Singapore 548957, Singapore
关键词
pangolin; intrinsic; disorder; protein; nucleocapsid; virulence; shell; COVID; coronavirus; vaccine; immune; antibody; nucleoprotein; membrane; matrix; attenuate; severe acute respiratory; omicron; MOLECULAR RECOGNITION FEATURES; INTRINSIC DISORDER; PROTEINS; NUCLEOPROTEIN; VIRULENCE; BINDING; VIRUS; ROLES; MORFS;
D O I
10.1021/acs.jproteome.2c00001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The shell disorder models have predicted that SARS-CoV-2 is of a specific but peculiarevolutionary nature. All coronaviruses (CoVs) closely related to SARS-CoV-2 have been found to have thehardest outer shells (M protein) among CoVs. This hard shell (low M percentage of intrinsic disorder(PID)) is associated with burrowing animals, for example, pangolins, and is believed to be responsible forthe high contagiousness of SARS-CoV-2 because it will be more resistant to antimicrobial enzymes found insaliva/mucus. Incoming clinical and experimental data do support this along with a prediction based onanother aspect of the shell (N, inner shell) disorder models that SARS-CoV-1 is more virulent than SARS-CoV-2 because SARS-CoV-2 produces fewer virus copies in vital organs even if large amounts of infectionsparticles are shed orally and nasally. A phylogenetic study using M reveals a closer relationship of SARS-CoV to pangolin-CoVs than the bat-RaTG13 found in Yunnan, China. Previous studies may have beenconfused by recombinations that were poorly handled. The shell disorder models suggest that a pangolin-CoV strain may have entered the human population in 2017 or before as an attenuated virus, which couldexplain why SARS-CoV is found to be highly adapted to humans
引用
收藏
页码:874 / 890
页数:17
相关论文
共 50 条
  • [41] SARS-CoV-2 specific antibody responses in COVID-19 infected and uninfected individuals
    Oktelik, Fatma Betul
    Yilmaz, Vuslat
    Gelmez, Metin Yusuf
    Akdeniz, Nilgun
    Deniz, Gunnur
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 217 - 217
  • [42] SARS-CoV-2 spike protein: Site-specific breakpoints for the development of COVID-19 vaccines
    Velusamy, Palaniyandi
    Kiruba, Kannan
    Su, Chia-Hung
    Arun, Viswanathan
    Anbu, Periasamy
    Gopinath, Subash C. B.
    Vaseeharan, Baskaralingam
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2021, 33 (08)
  • [43] The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients
    Chen, Hao
    Zhang, Xinyu
    Liu, Wanjun
    Xue, Mingshan
    Liao, Chenxi
    Huang, Zhifeng
    Hu, Haisheng
    Sun, Baoqing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 91
  • [44] An Evolutionary Portrait of the Progenitor SARS-CoV-2 and Its Dominant Offshoots in COVID-19 Pandemic
    Kumar, Sudhir
    Tao, Qiqing
    Weaver, Steven
    Sanderford, Maxwell
    Caraballo-Ortiz, Marcos A.
    Sharma, Sudip
    Pond, Sergei L. K.
    Miura, Sayaka
    Yeager, Meredith
    MOLECULAR BIOLOGY AND EVOLUTION, 2021, 38 (08) : 2021 - 3059
  • [45] Mapping the Evolutionary Space of SARS-CoV-2 Variants to Anticipate Emergence of Subvariants Resistant to COVID-19 Therapeutics
    Chavez, Roberth Anthony Rojas
    Fili, Mohammad
    Han, Changze
    Rahman, Syed A.
    Bicar, Isaiah G. L.
    Gregory, Sullivan
    Helverson, Annika
    Hu, Guiping
    Darbro, Benjamin W.
    Das, Jishnu
    Brown, Grant D.
    Haim, Hillel
    PLOS COMPUTATIONAL BIOLOGY, 2024, 20 (06)
  • [46] SARS-CoV-2/COVID-19: Evidence-Based Recommendations on Diagnosis and Therapy
    Bein, Berthold
    Bachmann, Martin
    Huggett, Susanne
    Wegermann, Petra
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (05) : 491 - 498
  • [47] Sinonasal pathophysiology of SARS-CoV-2 and COVID-19: A systematic review of the current evidence
    Gengler, Isabelle
    Wang, James C.
    Speth, Marlene M.
    Sedaghat, Ahmad R.
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2020, 5 (03): : 354 - 359
  • [48] Evidence of SARS-CoV-2 Virus in the Middle Ear of Deceased COVID-19 Patients
    Jeican, Ionut Isaia
    Aluas, Maria
    Lazar, Mihaela
    Barbu-Tudoran, Lucian
    Gheban, Dan
    Inisca, Patricia
    Albu, Camelia
    Tripon, Septimiu
    Albu, Silviu
    Siserman, Costel
    Vica, Mihaela Laura
    Muntean, Monica
    Opincariu, Iulian
    Junie, Lia Monica
    DIAGNOSTICS, 2021, 11 (09)
  • [49] The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic
    da Silva Torres, Maria Karoliny
    Bichara, Carlos David Araujo
    de Almeida, Maria de Nazare do Socorro
    Vallinoto, Mariana Cayres
    Queiroz, Maria Alice Freitas
    Vallinoto, Izaura Maria Vieira Cayres
    dos Santos, Eduardo Jose Melo
    de Carvalho, Carlos Alberto Marques
    Vallinoto, Antonio Carlos R.
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [50] SARS-CoV-2 AND COVID-19: FROM THE BENCH TO THE BEDSIDE
    Romagnoli, Stefano
    Peris, Adriano
    De Gaudio, A. Raffaele
    Geppetti, Pierangelo
    PHYSIOLOGICAL REVIEWS, 2020, 100 (04) : 1455 - 1466